XML 23 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Note 5 - Loans
3 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
Loans Collateralizing Asset Backed Securities Issued and Loans Held for Sale [Text Block]
5
.
Loans 
 
Allowance for Loan Losses
 
During the period ending
March 31, 2019,
the Company deconsolidated its investments in the CLOs and as a result,
no
longer has loans collateralizing ABS on its Consolidated Statement of Financial Condition as of
March 31, 2019.
See Note
1
for additional information on deconsolidation. A summary of the activity in the allowance for loan losses for the
three
months ended
March 31, 2019 
and
2018
 is as follows:
 
(In thousands)
 
Three Months Ended March 31,
 
   
2019
 
 
2018
 
   
Impaired
   
Non-Impaired
   
Impaired
   
Non-Impaired
 
Balance, at beginning of period
  $
(836
)   $
(9,751
)   $
(391
)   $
(6,533
)
Reversal (provision) for loan losses:
                               
Specific reserve
   
-
     
-
     
(953
)    
-
 
General reserve
   
-
     
-
     
-
     
41
 
Charge off
   
181
     
-
     
135
     
-
 
Derecognition due to deconsolidation
   
655
     
9,751
     
-
     
-
 
Balance, at end of period
  $
-
    $
-
    $
(1,209
)   $
(6,492
)
 
A loan is considered to be impaired when, based on current information, it is probable that the Company will be unable to collect all amounts due in accordance with the contractual terms of the original loan agreement, including scheduled principal and interest payments. As of
December 31, 2018, 
$1.8
million of the recorded investment amount in loans collateralizing asset-backed securities issued were individually evaluated for impairment. The remaining 
$1,170.2
million of recorded investment amount of loans collateralizing asset-backed securities issued were collectively evaluated for impairment as of
December 31, 2018.
 
As of
 
December 31, 2018 
the Company classified all its loans as Cash Flow loans, as their funding decisions were all primarily driven by the cash flows of the borrower. The table below presents certain information pertaining to the loans on non-accrual status at 
December 31, 2018:
 
(In thousands)
 
Recorded Investment
   
Unpaid Principal
Balance
   
Related Allowance
   
Average Recorded
Investment
   
Interest Income
Recognized
 
December 31, 2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Impaired loans with an allowance recorded
  $
1,813
    $
1,951
    $
838
    $
1,817
    $
119
 
Impaired loans with no related allowance recorded
   
-
     
-
     
-
     
-
     
-
 
Total impaired loans
  $
1,813
    $
1,951
    $
838
    $
1,817
    $
119
 
 
Loans are considered past due if the required principal and interest payments have
not
been received as of the date such payments were du
e.
No
loans were past due a
t M
arch
31,
2019
 or
December 31, 2018.
During the year ended
December 31, 2018,
the Company had
two
 loans, which were modif
ied in a troubled debt res
tructuring. The loans, with a principal balance and a carrying balance of
$1.9
million and
$1.0
million in total, respectively, were converted to equity. The Company valued the equity at
$0.8
million in total upon conversion and incurred a loss of
$0.1
million in relation to the restructuring as of 
December 31, 2018. 
 
The
Company had
one
troubled debt restructuring during the
three
months ended Ma
rch
31,
2019.
The loan, with a principal balance and a carrying balance of
$0.5
million and
$0.2
 million in total, respectively, was converted to equity. The Company valued the equity at
$0.2
 million in total upon conversion.
 
The Company
’s management, at least on a quarterly basis, reviews each loan and evaluates the credit quality of the loan. The review primarily includes the following credit quality indicators with regard to each loan:
1
) Moody’s rating,
2
) current internal rating,
3
) the trading price of the loan and
4
) performance of the obligor. The tables below present, by credit quality indicator, the Company’s recorded investment in loans collateralizing asset-backed securities issued at
December 31, 2018. These loans were deconsolidated as of March 31, 2019.
 
(In thousands)
   
Cash Flow Loans
 
 
 
 
March 31,
   
December 31,
 
 
 
 
2019
   
2018
 
                   
Moody's rating:
   
 
 
 
 
 
 
 
Baa1 - Baa3
    $
-
    $
7,300
 
Ba1 - Ba3
     
-
     
247,686
 
B1 - B3
     
-
     
856,204
 
Caa1 - Caa3
     
-
     
59,046
 
Ca
     
-
     
1,813
 
Total:
    $
-
    $
1,172,049
 
                   
Internal rating:
(1)
   
 
 
 
 
 
 
 
2     $
-
    $
1,018,261
 
3      
-
     
132,169
 
4      
-
     
19,806
 
5      
-
     
1,813
 
Total:
    $
-
    $
1,172,049
 
                   
Performance:
   
 
 
 
 
 
 
 
Performing
    $
-
    $
1,170,236
 
Non-Performing
     
-
     
1,813
 
Total:
    $
-
    $
1,172,049
 
 
(
1
)
Loans with an internal rating of
3
 or below are reviewed individually to identify loans to be designated for non-accrual status.
 
Loans Held for Investment
 
At
March 31, 2019 
and
December 31, 2018,
the number of loans held for investment outside of the CLO warehouse portfolio was
seven
and five, respectively. The Company reviews credit quality of these loans within this portfolio segment on a loan by loan basis mainly focusing on the borrower’s financial position and results of operations as well as the current and expected future cash flows on the loans. As of 
December 31, 2018,
the Company held
$26.0
million of loans held for investment in the CLO VI warehouse portfolio. The credit quality of the CLO VI warehouse loans are evaluated in the same manner as the credit quality of loans collateralizing asset-backed securities issued. During the
three
-month period ended
March 31, 2019,
the Company deconsolidated its investments in the CLO VI warehouse and a result,
no
longer has loans held for investment related to CLO VI on its Consolidated Statement of Financial Condition as of
March 31, 2019.
See Note
1
 for additional information on deconsolidation.
 
Ther
e were
no
loans past due as of
March 31, 2019 
and
March 31, 2018. 
A summary of activity in loan losses for the
three
months ended
March 31, 2019
and
2018
is as follows:
 
(in thousands)
 
Three Months Ended March 31,
 
   
2019
 
 
2018
 
   
Impaired
   
Non-impaired
   
Impaired
   
Non-impaired
 
Balance, at beginning of the period
  $
(218
)   $
(181
)   $
(2,279
)   $
(494
)
Provision for loan losses
                               
Specific
   
-
     
-
     
(205
)    
-
 
General
   
-
     
-
     
-
     
(364
)
Charge off
   
218
     
-
     
2,279
     
-
 
Derecognition due to deconsolidation    
-
     
181
     
-
     
-
 
Balance, at end of the period
  $
-
    $
-
    $
(205
)   $
(858
)
 
  A loan is considered to be impaired when, based on current information, it is probable that the Company will be unable to collect all amounts due in accordance with the contractual terms of the original loan agreement, including scheduled principal and interest payments. As of
March 31, 2019 
and 
December 31, 2018,
zero
and 
$0.5
million of recorded investment amount of loans issued were individually evaluated for impairment, respectively. 
 
The
Company had
one
troubled debt restructuring during the
three
months ended Ma
rch
31,
2019.
The loan, with a principal balance and a carrying balance of
$0.5
million and
$0.2
 million in total, respectively, was converted to equity. The Company valued the equity at
$0.2
 million in total upon conversion.
 
  As of
December 31, 2018,
the Company classified all its loans as Cash Flow loans, as their funding decisions were all primarily driven by the cash flows of the borrower. There were
no
impaired loans on non-accrual status as of
March 31, 2019.
The table below presents certain information pertaining to the loans on non-accrual status as of 
December 31, 2018:
 
   
Recorded Investment
   
Unpaid Principal
   
Related Allowance
   
Average Recorded
Investment
   
Interest Income
Recognized
 
December 31, 2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Impaired loans with an allowance recorded
  $
462
    $
484
    $
218
    $
462
    $
34
 
Impaired loans with no related allowance recorded
   
-
     
-
     
-
     
-
     
-
 
Total impaired loans
  $
462
    $
484
    $
218
    $
462
    $
34
 
 
The Company's management, at least on a quarterly basis, reviews each loan and evaluates the credit quality of the loan. The review primarily includes the following credit quality indicators with regard to each loan:
1
) Moody's rating,
2
) current internal rating,
3
) trading price of the loan, and
4
) performance of the obligor. The table below presents, by credit quality indicator, the Company's recorded investment in loans held for investment at
March 31, 2019 
and 
December 31, 2018:
 
(In thousands)
   
Cash Flow Loans
 
 
 
 
March 31,
   
December 31,
 
 
 
 
2019
   
2018
 
                   
Moody's rating:
   
 
 
 
 
 
 
 
Baa1 - Baa3
    $
-
    $
-
 
Ba1 - Ba3
     
-
     
7,459
 
B1 - B3
     
-
     
18,342
 
Caa1 - Caa3
     
-
     
419
 
Ca
     
-
     
463
 
Not Rated
     
4,853
     
3,326
 
Total:
    $
4,853
    $
30,009
 
                   
Internal rating
(1)
:
   
 
 
 
 
 
 
 
2     $
1,539
    $
26,208
 
3      
885
     
909
 
4      
-
     
-
 
5      
-
     
462
 
Not rated
     
2,429
     
2,430
 
Total:
    $
4,853
    $
30,009
 
                   
Performance:
   
 
 
 
 
 
 
 
Performing
    $
4,853
    $
29,547
 
Non-performing
     
-
     
462
 
Total:
    $
4,853
    $
30,009
 
 
(
1
) Loans with an internal rating of
4
or below are reviewed individually to identify loans to be designated for non-accrual status.